NOTV Live-Signale | Maximieren Sie Profite mit Getagraph.com

VERKAUFEN 108216 min ago

@ $5.33

Ausgestellt: 14 Feb 2024 @ 15:32

Rendite: -27.18%

Vorheriges Signal: Feb 12 - 21:18

Vorheriges Signal: Kaufen

Rendite: -3.44 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 20:08):

Stats
Tagesvolumen	315 659
Durchschnittsvolumen	477 041
Marktkapitalisierung	100.20M
EPS	$-0.290 ( 2024-02-07 )
Nächstes Ertragsdatum	( $0.0500 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.01
ATR14	$0.00900 (0.23%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-14	Harrington Michael J	Buy	0
2019-06-07	Leasure Robert Jr.	Buy	7 500	Common Stock
2019-01-12	Leasure Robert Jr.	Buy	0	Common Stock
2024-01-15	Castetter Andrea	Buy	10 000	Employee Stock Option (right to buy)
2023-03-30	Beraldi Fernanda	Buy	2 500	Common Stock

INSIDER POWER
35.83
Last 80 transactions
Buy: 1 308 593 \| Sell: 919 981

Volumen Korrelation

Lang: -0.36 (neutral)

Kurz: -1.00 (very strong negative)

Signal:(16.839) Possible Trading Opportunity Present (swing)

Bioanalytical Systems Inc Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Bioanalytical Systems Inc Korrelation - Währung/Rohstoff

-0.69
( moderate negative )

-0.70
( moderate negative )

0.00
( neutral )

-0.83
( strong negative )

0.66
( moderate )

0.84
( strong )

Bioanalytical Systems Inc Finanzdaten

Annual	2023
Umsatz:	$572.43M
Bruttogewinn:	$165.44M (28.90 %)
EPS:	$-4.10

FY	2023
Umsatz:	$572.43M
Bruttogewinn:	$165.44M (28.90 %)
EPS:	$-4.10

FY	2022
Umsatz:	$547.66M
Bruttogewinn:	$157.21M (28.71 %)
EPS:	$-13.85

FY	2021
Umsatz:	$89.61M
Bruttogewinn:	$30.16M (33.65 %)
EPS:	$0.830

Financial Reports:

No articles found.

Bioanalytical Systems Inc

Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.